Even as the clinical community works to establish the long-term benefits of current GLP-1 and HRT combinations, a new generation of metabolic therapies is already moving through trials, ones that extend the biological logic of this article's central argument into territory that semaglutide and tirzepatide alone cannot reach
It cautions that oral formulations and delivery enhancers may behave differently and are less studied
Metabolic & Insulin-Regulating Peptides These peptides primarily target insulin resistance, a key driver in PCOS
Retatrutide is not approved in the UK, so there is no licensed 12mg dose for patients
Significant alterations in CNS-resident immune cells often follow changes in the gut microbiota
Taking Berberine led to a significant decrease in hemoglobin A1c from 9.5 to 7.5, fasting blood glucose from 10.6 to 6.9, and postprandial blood glucose from 19.8 to 11.1